191 related articles for article (PubMed ID: 17079302)
21. Modification of the genetic program of human alveolar macrophages by adenovirus vectors in vitro is feasible but inefficient, limited in part by the low level of expression of the coxsackie/adenovirus receptor.
Kaner RJ; Worgall S; Leopold PL; Stolze E; Milano E; Hidaka C; Ramalingam R; Hackett NR; Singh R; Bergelson J; Finberg R; Falck-Pedersen E; Crystal RG
Am J Respir Cell Mol Biol; 1999 Mar; 20(3):361-70. PubMed ID: 10030833
[TBL] [Abstract][Full Text] [Related]
22. Defining a Novel Role for the Coxsackievirus and Adenovirus Receptor in Human Adenovirus Serotype 5 Transduction
Lopez-Gordo E; Doszpoly A; Duffy MR; Coughlan L; Bradshaw AC; White KM; Denby L; Nicklin SA; Baker AH
J Virol; 2017 Jun; 91(12):. PubMed ID: 28381574
[TBL] [Abstract][Full Text] [Related]
23. What does it take to bind CAR?
Law LK; Davidson BL
Mol Ther; 2005 Oct; 12(4):599-609. PubMed ID: 16109509
[TBL] [Abstract][Full Text] [Related]
24. Structure of the fiber head of Ad3, a non-CAR-binding serotype of adenovirus.
Durmort C; Stehlin C; Schoehn G; Mitraki A; Drouet E; Cusack S; Burmeister WP
Virology; 2001 Jul; 285(2):302-12. PubMed ID: 11437664
[TBL] [Abstract][Full Text] [Related]
25. Adenovirus type 5 substituted with type 11 or 35 fiber structure increases its infectivity to human cells enabling dual gene transfer in CD46-dependent and -independent manners.
Yu L; Shimozato O; Li Q; Kawamura K; Ma G; Namba M; Ogawa T; Kaiho I; Tagawa M
Anticancer Res; 2007; 27(4B):2311-6. PubMed ID: 17695519
[TBL] [Abstract][Full Text] [Related]
26. Adenovirus type 11 uses CD46 as a cellular receptor.
Segerman A; Atkinson JP; Marttila M; Dennerquist V; Wadell G; Arnberg N
J Virol; 2003 Sep; 77(17):9183-91. PubMed ID: 12915534
[TBL] [Abstract][Full Text] [Related]
27. Biodistribution of radioiodinated adenovirus fiber protein knob domain after intravenous injection in mice.
Awasthi V; Meinken G; Springer K; Srivastava SC; Freimuth P
J Virol; 2004 Jun; 78(12):6431-8. PubMed ID: 15163736
[TBL] [Abstract][Full Text] [Related]
28. Retargeting the coxsackievirus and adenovirus receptor to the apical surface of polarized epithelial cells reveals the glycocalyx as a barrier to adenovirus-mediated gene transfer.
Pickles RJ; Fahrner JA; Petrella JM; Boucher RC; Bergelson JM
J Virol; 2000 Jul; 74(13):6050-7. PubMed ID: 10846088
[TBL] [Abstract][Full Text] [Related]
29. Protein transduction domains fused to virus receptors improve cellular virus uptake and enhance oncolysis by tumor-specific replicating vectors.
Kühnel F; Schulte B; Wirth T; Woller N; Schäfers S; Zender L; Manns M; Kubicka S
J Virol; 2004 Dec; 78(24):13743-54. PubMed ID: 15564483
[TBL] [Abstract][Full Text] [Related]
30. Susceptibility of B lymphocytes to adenovirus type 5 infection is dependent upon both coxsackie-adenovirus receptor and alphavbeta5 integrin expression.
Richardson C; Brennan P; Powell M; Prince S; Chen YH; Spiller OB; Rowe M
J Gen Virol; 2005 Jun; 86(Pt 6):1669-1679. PubMed ID: 15914844
[TBL] [Abstract][Full Text] [Related]
31. Factors limiting adenovirus-mediated gene transfer into human lung and pancreatic cancer cell lines.
Pearson AS; Koch PE; Atkinson N; Xiong M; Finberg RW; Roth JA; Fang B
Clin Cancer Res; 1999 Dec; 5(12):4208-13. PubMed ID: 10632362
[TBL] [Abstract][Full Text] [Related]
32. Identification of novel human adenovirus candidates using the coxsackievirus and adenovirus receptor for cell entry.
Mese K; Bunz O; Schellhorn S; Volkwein W; Jung D; Gao J; Zhang W; Baiker A; Ehrhardt A
Virol J; 2020 Apr; 17(1):52. PubMed ID: 32272960
[TBL] [Abstract][Full Text] [Related]
33. PED/PEA-15 modulates coxsackievirus-adenovirus receptor expression and adenoviral infectivity via ERK-mediated signals in glioma cells.
Botta G; Perruolo G; Libertini S; Cassese A; Abagnale A; Beguinot F; Formisano P; Portella G
Hum Gene Ther; 2010 Sep; 21(9):1067-76. PubMed ID: 20406097
[TBL] [Abstract][Full Text] [Related]
34. Structural analysis of the mechanism of adenovirus binding to its human cellular receptor, CAR.
Bewley MC; Springer K; Zhang YB; Freimuth P; Flanagan JM
Science; 1999 Nov; 286(5444):1579-83. PubMed ID: 10567268
[TBL] [Abstract][Full Text] [Related]
35. Expression of Coxsackie-Adenovirus receptor (CAR) in the developing mouse olfactory system.
Venkatraman G; Behrens M; Pyrski M; Margolis FL
J Neurocytol; 2005 Sep; 34(3-5):295-305. PubMed ID: 16841169
[TBL] [Abstract][Full Text] [Related]
36. Postinternalization inhibition of adenovirus gene expression and infectious virus production in human T-cell lines.
McNees AL; Mahr JA; Ornelles D; Gooding LR
J Virol; 2004 Jul; 78(13):6955-66. PubMed ID: 15194772
[TBL] [Abstract][Full Text] [Related]
37. Dimeric structure of the coxsackievirus and adenovirus receptor D1 domain at 1.7 A resolution.
van Raaij MJ; Chouin E; van der Zandt H; Bergelson JM; Cusack S
Structure; 2000 Nov; 8(11):1147-55. PubMed ID: 11080637
[TBL] [Abstract][Full Text] [Related]
38. Mouse adenovirus type 1 attachment is not mediated by the coxsackie-adenovirus receptor.
Lenaerts L; Daelemans D; Geukens N; De Clercq E; Naesens L
FEBS Lett; 2006 Jul; 580(16):3937-42. PubMed ID: 16806202
[TBL] [Abstract][Full Text] [Related]
39. Research advance on role of Coxsackie and adenovirus receptor (CAR) in tumor progression.
Fan LS; Chen G; Ma D
Ai Zheng; 2009 Mar; 28(3):333-6. PubMed ID: 19619453
[TBL] [Abstract][Full Text] [Related]
40. CD46 is a cellular receptor for all species B adenoviruses except types 3 and 7.
Marttila M; Persson D; Gustafsson D; Liszewski MK; Atkinson JP; Wadell G; Arnberg N
J Virol; 2005 Nov; 79(22):14429-36. PubMed ID: 16254377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]